A Study to Efficacy and Safety of CWP-0403 in Type 2 Diabetes Mellitus Patients

Summary

This trial is to evaluate the efficacy and safety of CWP-0403 at 100 mg or 200 mg twice daily compared with placebo in type 2 diabetic patients with inadequate glycemic control by diet therapy or combination of diet and exercise therapy.

Timeline

Start

2011-05

Primary completion

2012-09

Completion

2012-11

Drugs

Indications